Shi Ke, Carpenter Michael A, Kurahashi Kayo, Harris Reuben S, Aihara Hideki
Department of Biochemistry, Molecular Biology, and Biophysics; Institute for Molecular Virology; Masonic Cancer Center.
Department of Biochemistry, Molecular Biology, and Biophysics; Institute for Molecular Virology; Masonic Cancer Center.
J Biol Chem. 2015 Nov 20;290(47):28120-28130. doi: 10.1074/jbc.M115.679951. Epub 2015 Sep 28.
Functional and deep sequencing studies have combined to demonstrate the involvement of APOBEC3B in cancer mutagenesis. APOBEC3B is a single-stranded DNA cytosine deaminase that functions normally as a nuclear-localized restriction factor of DNA-based pathogens. However, it is overexpressed in cancer cells and elicits an intrinsic preference for 5'-TC motifs in single-stranded DNA, which is the most frequently mutated dinucleotide in breast, head/neck, lung, bladder, cervical, and several other tumor types. In many cases, APOBEC3B mutagenesis accounts for the majority of both dispersed and clustered (kataegis) cytosine mutations. Here, we report the first structures of the APOBEC3B catalytic domain in multiple crystal forms. These structures reveal a tightly closed active site conformation and suggest that substrate accessibility is regulated by adjacent flexible loops. Residues important for catalysis are identified by mutation analyses, and the results provide insights into the mechanism of target site selection. We also report a nucleotide (dCMP)-bound crystal structure that informs a multistep model for binding single-stranded DNA. Overall, these high resolution crystal structures provide a framework for further mechanistic studies and the development of novel anti-cancer drugs to inhibit this enzyme, dampen tumor evolution, and minimize adverse outcomes such as drug resistance and metastasis.
功能和深度测序研究共同证明了载脂蛋白B mRNA编辑酶催化多肽样3B(APOBEC3B)参与癌症诱变。APOBEC3B是一种单链DNA胞嘧啶脱氨酶,其正常功能是作为基于DNA的病原体的核定位限制因子。然而,它在癌细胞中过表达,并对单链DNA中的5'-TC基序表现出内在偏好,而5'-TC基序是乳腺癌、头颈癌、肺癌、膀胱癌、宫颈癌和其他几种肿瘤类型中最常发生突变的二核苷酸。在许多情况下,APOBEC3B诱变占分散和聚集(kataegis)胞嘧啶突变的大部分。在这里,我们报告了多种晶体形式的APOBEC3B催化结构域的首个结构。这些结构揭示了紧密闭合的活性位点构象,并表明底物可及性受相邻柔性环的调节。通过突变分析确定了对催化重要的残基,结果为靶位点选择机制提供了见解。我们还报告了一种结合核苷酸(dCMP)的晶体结构,该结构为结合单链DNA的多步模型提供了信息。总体而言,这些高分辨率晶体结构为进一步的机制研究和开发新型抗癌药物提供了框架,以抑制这种酶、抑制肿瘤进展并将耐药性和转移等不良后果降至最低。